Navigating a diagnosis of platinum-resistant ovarian cancer can feel overwhelming, but recent advancements and clinical trials are bringing new hope and more personalized treatment paths. This program offers empowering information on the latest therapies. We are joined by Dr. Kathleen Moore, an internationally recognized leader in gynecologic oncology from the Stephenson Cancer Center, who breaks down what you need to know about where treatment is heading.

What to expect:

• Understand Platinum Resistance: Learn what this diagnosis means and how it shapes your treatment options
• Discover Emerging Therapies: Hear about the promise of antibody-drug conjugates (ADCs) and other new drugs that are improving survival
• Learn About Biomarker Testing: Find out how tests for markers like folate receptor and BRCA can unlock personalized treatment paths
• Explore Clinical Trials: Get clear answers about how to find and access clinical trials for new and promising ovarian cancer treatments
• Personalize Your Care: Learn how oncologists are sequencing therapies to create more effective, individualized treatment plans
• Advocate for Yourself: Gain insights on communicating with your doctor and the questions to ask to ensure you get the best care